Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|November 4, 2005
Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 proteinBjorn Carlsson, Mingyan Hou, Valeria Giandomenico, et al.
British Journal of Cancer|May 31, 2017
Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in miceMiika Martikainen, Janne Ruotsalainen, Johanna Tuomela, et al.
Frontiers in Immunology|September 20, 2021
Tertiary Lymphoid Structures in the Central Nervous System: Implications for GlioblastomaTiarne van de Walle, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Cell Transplantation|May 16, 2012
Islet engraftment and revascularization in clinical and experimental transplantationChristian Molnár, Magnus Essand, Lars Wennberg, et al.
Journal of Virology|September 30, 2011
Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumorsDi Yu, Chuan Jin, Justyna Leja, et al.
Molecular Therapy. Nucleic Acids|November 25, 2024
Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon responseArwa Ali, Paola Contreras, Mahmoud Darweesh, et al.
Human Gene Therapy. Clinical Development|March 22, 2014
Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancerEllen Schenk, Magnus Essand, Robert Kraaij, et al.
The Prostate|September 25, 2008
High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individualsOle Forsberg, Björn Carlsson, Per-Uno Malmström, et al.
Plos One|January 30, 2010
Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing abilityJustyna Leja, Berith Nilsson, Di Yu, et al.
Neuroendocrinology|July 22, 2016
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine CancerDi Yu, Justyna Leja-Jarblad, Angelica Loskog, et al.
Pageof 9